David M. Vigushin

Human lysozyme gene mutations cause hereditary systemic amyloidosis

Mark B. Pepys, Philip N. Hawkins, David R. Booth et al. · Nature · 1993 · 660 citations

Life Sciences, Genetics, Molecular Biology +12

Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.

David M. Vigushin, Mark B. Pepys, Philip N. Hawkins · Journal of Clinical Investigation · 1993 · 642 citations · Full text

Medicine, Nuclear Medicine, Pharmacokinetics +16

Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.

David M. Vigushin, Simak Ali, Paul Pace et al. · PubMed · 2001 · 442 citations

Medicine, Oncology, Pharmacology +10

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography

Laura Kenny, R. Charles Coombes, David M. Vigushin et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 275 citations

Medicine, Oncology, Radiology +17

Phase I and pharmacokinetic study of d -limonene in patients with advanced cancer

David M. Vigushin, Grace K. Poon, Alan V. Boddy et al. · Cancer Chemotherapy and Pharmacology · 1998 · 249 citations

Pharmacy, Pharmacokinetics, Pharmacology +11